83 related articles for article (PubMed ID: 25209879)
1. Evaluation of serum iron overload, AST:ALT ratio and log
Owiredu WKBA; Brenya PK; Osei Y; Laing EF; Okrah CO; Obirikorang C; Anto EO; Acheampong E; Donkor S
BMC Res Notes; 2019 Dec; 12(1):802. PubMed ID: 31831048
[TBL] [Abstract][Full Text] [Related]
2. [Effects of pre-immunosupressive therapy iron overload on hematologic response of severe aplastic anemia].
Ye L; Jing L; Peng G; Zhou K; Li Y; Li Y; Li J; Fan H; Yang W; Zhang F; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):324-8. PubMed ID: 27093997
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of therapeutic phlebotomies: Prospective study of 587 procedures.
Romón I; Domíguez-García J; Fernández C; Carretón M; Martínez N; Calzada L; Cortés MA; Mendez GA; Gorostidi I; Briz M; Ocio E
Transfusion; 2024 May; ():. PubMed ID: 38708765
[TBL] [Abstract][Full Text] [Related]
4. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.
Taher AT; Porter JB; Viprakasit V; Kattamis A; Chuncharunee S; Sutcharitchan P; Siritanaratkul N; Origa R; Karakas Z; Habr D; Zhu Z; Cappellini MD
Br J Haematol; 2015 Jan; 168(2):284-90. PubMed ID: 25212456
[TBL] [Abstract][Full Text] [Related]
5. A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.
Rombout-Sestrienkova E; Winkens B; van Kraaij M; van Deursen CTBM; Janssen MCH; Rennings AMJ; Evers D; Kerkhoffs JL; Masclee A; Koek GH
J Clin Apher; 2021 Jun; 36(3):340-347. PubMed ID: 33368569
[TBL] [Abstract][Full Text] [Related]
6. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
7. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation.
Adams PC; Barton JC
J Hepatol; 2011 Aug; 55(2):453-8. PubMed ID: 21354228
[TBL] [Abstract][Full Text] [Related]
8. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.
Panch SR; Yau YY; West K; Diggs K; Sweigart T; Leitman SF
Transfusion; 2015 Mar; 55(3):611-22. PubMed ID: 25209879
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
10. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
[TBL] [Abstract][Full Text] [Related]
11. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
12. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
Angelucci E; Muretto P; Lucarelli G; Ripalti M; Baronciani D; Erer B; Galimberti M; Giardini C; Gaziev D; Polchi P
Blood; 1997 Aug; 90(3):994-8. PubMed ID: 9242528
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants.
Barton JC; Barton JC; Adams PC
Ann Hepatol; 2017; 16(5):802-811. PubMed ID: 28809726
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial.
Jaspers A; Baron F; Willems E; Seidel L; Hafraoui K; Vanstraelen G; Bonnet C; Beguin Y
Blood; 2014 Jul; 124(1):33-41. PubMed ID: 24850754
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
